AVGO vs NXPI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Broadcom exhibits a dichotomy between elite operational performance and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable health, the stock trades at a massive premium to its Graham Number ($44.08) and Intrinsic Value ($151.04). This valuation gap is partially justified by a very attractive PEG ratio (0.68) and strong forward P/E (19.65), suggesting high growth expectations. However, aggressive insider selling by the CEO and CFO, combined with a bearish technical trend, offsets the strong analyst 'strong_buy' consensus.
NXP Semiconductors trades at $197.10, down 10.3% over the past year amid sector-wide semiconductor volatility, yet exhibits strong fundamental resilience and superior profitability relative to peers. Despite near-term revenue contraction (-2.4% YoY), the company maintains best-in-class margins—gross margin of 55.4%, operating margin of 28.24%, and ROE of 20.87%—signaling pricing power and operational efficiency. Forward P/E of 15.08 appears compelling versus sector average P/E of 138.37 and an analyst target price of $258.43, implying 31% upside. Bullish sentiment is reinforced by consistent earnings beats over the last five years and a sustainable 2.06% dividend yield with a 50% payout ratio, though recent insider selling introduces mild caution.
Compare Another Pair
Related Comparisons
AVGO vs NXPI: Head-to-Head Comparison
This page compares Broadcom Inc. (AVGO) and NXP Semiconductors N.V. (NXPI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.